Pulse nav.journalClub Trends Entdecken Fragen Forschende

Download the App

Join discussions, follow papers, and never miss your next session.

© Synapse Social LLC, 2026Datenschutz

Start Entdecken nav.journalClub Trends

⌘+K

March 25, 2026

Portuguese consensus for the use of cladribine tablets in multiple sclerosis

Key Points

To establish guidelines for the use of cladribine tablets in treating relapsing remitting multiple sclerosis (RRMS).
Reviewed clinical trials on cladribine tablets
Analyzed real-world studies for efficacy and safety
Consolidated expert consensus on treatment practices
Cladribine tablets showed significant efficacy in reducing relapses in RRMS.
Safety profile aligns with other disease-modifying therapies.
Guidelines aim to standardize treatment decisions among clinicians.

Abstract

This study guides the use of cladribine tablets in clinical practice, supporting treatment decision-making in patients with RRMS, and summarizes the current knowledge from clinical trials and real-world studies of the efficacy and safety of cladribine tablets.

Like

Bookmark

Share

Like

Bookmark

Share

Portuguese consensus for the use of cladribine tablets in multiple sclerosis | Synapse

Cite This Study

Sá et al. (Mon,) studied this question.

synapsesocial.com/papers/69c37af0b34aaaeb1a67cedc https://doi.org/https://doi.org/10.1080/17582024.2026.2647105